Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
Crocker
J F
JF
Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Schenk
M E
ME
Hamilton
D A
DA
Cole
D E
DE
McDonald
A T
AT
Acott
P D
PD
D000818:Animals; D000831:Animals, Newborn; D013956:Antithyroid Agents / Q000494:pharmacology; D005938:Glucocorticoids / Q000633:toxicity*; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced; D008775:Methylprednisolone / Q000031:analogs & derivatives* / Q000633:toxicity; D000077555:Methylprednisolone Acetate; D051379:Mice; D008810:Mice, Inbred C57BL; D007690:Polycystic Kidney Diseases / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D011441:Propylthiouracil / Q000494:pharmacology; D013972:Thyrotropin / Q000097:blood; D014284:Triiodothyronine / Q000494:pharmacology*
D013956:Antithyroid Agents; D005938:Glucocorticoids; D014284:Triiodothyronine; D000077555:Methylprednisolone Acetate; D011441:Propylthiouracil; D013972:Thyrotropin; D008775:Methylprednisolone